Peoples Bancorp's positive quarterly results show strong deposit management, sustainable dividends, and conservative loan ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

GoDaddy (GDDY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most ...

Bitfarms Ltd. (BITF) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

The latest Apple stock downgrade centers around iPhone sales and the weakening consumer electronics market. Here's what ...

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks. A “buy” rating ...

These three smaller-cap companies with lower-priced stocks could offer patient investors enormous returns for the rest of 2025 and beyond.

Confluent stock is currently down 71% from its all-time high, which was set during the tech frenzy in 2021. It was unquestionably overvalued back then, but the majority of analysts tracked by The Wall ...

Stocks trading under $10 can be attractive for investors looking to scoop up some cheap shares. Unfortunately, quality stocks ...